Eric Bjerkholt

Insider Reports History

Entity
Individual
Location
132 Purdure Avenue, Kengsington, CA
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Bjerkholt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. CHIEF FINANCIAL OFFICER Restricted Stock Units 36.7K $1.52M $41.58 Sep 11, 2024 Direct
Mirum Pharmaceuticals, Inc. CHIEF FINANCIAL OFFICER Common Stock 32.8K $1.36M $41.58 Sep 11, 2024 Direct
CERUS CORP Director Common Stock 182K $911K $5.00 Jun 5, 2024 Direct
Mirum Pharmaceuticals, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 32K Jan 23, 2024 Direct
CalciMedica, Inc. Director Director Stock Option (Right to Buy) 10K Aug 27, 2024 Direct
Surrozen, Inc./DE Director Option (right to buy) 1.33K Jun 5, 2024 Direct
CHINOOK THERAPEUTICS, INC. Chief Financial Officer Common Stock 0 $39.03 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Chief Financial Officer Restricted Stock Units 0 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Chief Financial Officer Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct

Insider Reports Filed by Eric Bjerkholt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIRM Mirum Pharmaceuticals, Inc. Sep 11, 2024 2 $0 4 Sep 12, 2024 CHIEF FINANCIAL OFFICER
CALC CalciMedica, Inc. Aug 27, 2024 1 $0 4 Aug 28, 2024 Director
SRZN Surrozen, Inc./DE Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
CERS CERUS CORP Jun 5, 2024 1 $200K 4 Jun 6, 2024 Director
MIRM Mirum Pharmaceuticals, Inc. May 10, 2024 1 $9.89K 4 May 16, 2024 CHIEF FINANCIAL OFFICER
CALC CalciMedica, Inc. Mar 28, 2024 1 $0 4 Apr 22, 2024 Director
MIRM Mirum Pharmaceuticals, Inc. Mar 27, 2024 1 $49.6K 4 Mar 27, 2024 CHIEF FINANCIAL OFFICER
MIRM Mirum Pharmaceuticals, Inc. Mar 18, 2024 1 $51.6K 4 Mar 18, 2024 CHIEF FINANCIAL OFFICER
MIRM Mirum Pharmaceuticals, Inc. Jan 23, 2024 2 $0 4 Jan 25, 2024 CHIEF FINANCIAL OFFICER
CERS CERUS CORP Dec 13, 2023 1 $16.2K 4 Dec 13, 2023 Director
MIRM Mirum Pharmaceuticals, Inc. Sep 11, 2023 3 $296K 4 Sep 12, 2023 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. Sep 11, 2023 0 $0 3 Sep 12, 2023 Chief Financial Officer
CERS CERUS CORP Aug 21, 2023 1 $17.2K 4 Aug 23, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 10 -$7.92M 4 Aug 11, 2023 Chief Financial Officer
CERS CERUS CORP Jun 7, 2023 1 $200K 4 Jun 9, 2023 Director
CALC CalciMedica, Inc. May 30, 2023 3 $1.06K 4 Jun 1, 2023 Director
CALC CalciMedica, Inc. May 23, 2023 1 $1.63K 4 May 24, 2023 Director
CERS CERUS CORP May 23, 2023 1 $10K 4 May 23, 2023 Director
CALC CalciMedica, Inc. May 18, 2023 2 $530 4 May 22, 2023 Director
SRZN Surrozen, Inc./DE May 18, 2023 1 $0 4 May 19, 2023 Director
CALC CalciMedica, Inc. May 16, 2023 3 $3.5K 4 May 18, 2023 Director
CALC CalciMedica, Inc. May 8, 2023 1 $0 4 Jun 28, 2023 Director
SRZN Surrozen, Inc./DE Apr 5, 2023 0 $0 3 Apr 5, 2023 Director
CALC CalciMedica, Inc. Mar 23, 2023 2 $0 4 Mar 27, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Feb 10, 2023 3 -$20.4K 4 Feb 15, 2023 Chief Financial Officer
KDNY CHINOOK THERAPEUTICS, INC. Jan 31, 2023 5 -$71.4K 4 Feb 2, 2023 Chief Financial Officer
KDNY CHINOOK THERAPEUTICS, INC. Nov 30, 2022 3 -$129K 4 Dec 2, 2022 Chief Financial Officer
CALC GRAYBUG VISION, INC. Jun 2, 2022 2 $0 4 Jun 3, 2022 Director
CERS CERUS CORP Jun 1, 2022 2 $0 4 Jun 3, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Feb 10, 2022 3 -$11.4K 4 Feb 14, 2022 Chief Financial Officer
KDNY CHINOOK THERAPEUTICS, INC. Jan 31, 2022 2 $0 4 Feb 2, 2022 Chief Financial Officer
KDNY CHINOOK THERAPEUTICS, INC. Dec 1, 2021 3 -$92.1K 4 Dec 3, 2021 Chief Financial Officer
CALC GRAYBUG VISION, INC. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
CERS CERUS CORP Jun 1, 2021 4 $0 4 Jun 3, 2021 Director